NO970356L - PTH eller PTHrP antagonister - Google Patents

PTH eller PTHrP antagonister

Info

Publication number
NO970356L
NO970356L NO970356A NO970356A NO970356L NO 970356 L NO970356 L NO 970356L NO 970356 A NO970356 A NO 970356A NO 970356 A NO970356 A NO 970356A NO 970356 L NO970356 L NO 970356L
Authority
NO
Norway
Prior art keywords
pth
amino acid
pthrp
tryptophan
aromatic
Prior art date
Application number
NO970356A
Other languages
English (en)
Norwegian (no)
Other versions
NO970356D0 (no
Inventor
Francois Cardinaux
Jean Honore M Feyen
Rainer Gamse
Frank Otto Gombert
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415254A external-priority patent/GB9415254D0/en
Priority claimed from GB9415255A external-priority patent/GB9415255D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO970356D0 publication Critical patent/NO970356D0/no
Publication of NO970356L publication Critical patent/NO970356L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO970356A 1994-07-28 1997-01-28 PTH eller PTHrP antagonister NO970356L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9415254A GB9415254D0 (en) 1994-07-28 1994-07-28 Organic compounds
GB9415255A GB9415255D0 (en) 1994-07-28 1994-07-28 Organic compounds
PCT/EP1995/002993 WO1996003437A1 (en) 1994-07-28 1995-07-27 PTH OR PTHrP ANTAGONISTS

Publications (2)

Publication Number Publication Date
NO970356D0 NO970356D0 (no) 1997-01-28
NO970356L true NO970356L (no) 1997-01-28

Family

ID=26305357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970356A NO970356L (no) 1994-07-28 1997-01-28 PTH eller PTHrP antagonister

Country Status (15)

Country Link
EP (1) EP0773958A1 (hu)
JP (1) JPH10502091A (hu)
AU (1) AU3167095A (hu)
BR (1) BR9508433A (hu)
CA (1) CA2192787A1 (hu)
CO (1) CO4410206A1 (hu)
CZ (1) CZ23397A3 (hu)
FI (1) FI970168A0 (hu)
HU (1) HUT77979A (hu)
IL (1) IL114736A0 (hu)
NO (1) NO970356L (hu)
PL (1) PL318017A1 (hu)
SK (1) SK12097A3 (hu)
TR (1) TR199500915A2 (hu)
WO (1) WO1996003437A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW505654B (en) * 1996-07-30 2002-10-11 Hoffmann La Roche Synthesis of analogs of PTH and PTHrP
ATE304020T1 (de) * 1996-07-31 2005-09-15 Gen Hospital Corp Parathyroidhormon-verwandthe peptidanaloge
US6903194B1 (en) 1996-09-26 2005-06-07 Chungai Seiyaku Kabushiki Kaisha Antibody against human parathormone related peptides
BR9808786A (pt) 1997-05-14 2000-07-11 Rhone Poulenc Rorer Pharma Composto peptìdio cìclico ou um seu sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, processos para tratar doenças associadas com a regulagem do cálcio em um paciente e para tratar a osteopenia ou a osteoporose em um mamìfero hospedeiro
US20020165363A1 (en) 1997-05-15 2002-11-07 Koh Sato Cachexia remedy
AU5708500A (en) * 1999-07-02 2001-01-22 Chugai Seiyaku Kabushiki Kaisha Remedies for diseases caused by pth or pthrp
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
AU5849700A (en) * 1999-07-06 2001-01-22 Chugai Seiyaku Kabushiki Kaisha Remedies for drug-resistant hypercalcemia
DE60024118T2 (de) * 1999-09-20 2006-07-27 Eli Lilly And Co., Indianapolis Verwendung einer parathyroidhormone zur reduktion des krebsrisikos
WO2001054725A1 (fr) * 2000-01-25 2001-08-02 Chugai Seiyaku Kabushiki Kaisha Remèdes et agents prophylactiques pour maladies dentaires
CA2401357A1 (en) * 2000-02-28 2001-09-07 Chugai Seiyaku Kabushiki Kaisha Tissue degradation inhibitor agent
WO2001082968A1 (fr) 2000-04-28 2001-11-08 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation cellulaire
WO2002013865A1 (fr) * 2000-08-16 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agents destines a soulager les symptomes provoques par des maladies articulaires
US8568737B2 (en) 2007-08-01 2013-10-29 The General Hospital Corporation Screening methods using G-protein coupled receptors and related compositions
JP5941040B2 (ja) 2010-05-13 2016-06-29 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン類似体およびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
EP0539491A1 (en) * 1990-07-13 1993-05-05 The Regents Of The University Of California PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments

Also Published As

Publication number Publication date
EP0773958A1 (en) 1997-05-21
NO970356D0 (no) 1997-01-28
PL318017A1 (en) 1997-05-12
TR199500915A2 (tr) 1996-06-21
IL114736A0 (en) 1995-11-27
CO4410206A1 (es) 1997-01-09
FI970168A (fi) 1997-01-15
BR9508433A (pt) 1998-07-14
JPH10502091A (ja) 1998-02-24
SK12097A3 (en) 1997-08-06
HUT77979A (hu) 1999-01-28
MX9700446A (es) 1998-06-28
CZ23397A3 (en) 1997-07-16
CA2192787A1 (en) 1996-02-08
FI970168A0 (fi) 1997-01-15
AU3167095A (en) 1996-02-22
WO1996003437A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
NO970356L (no) PTH eller PTHrP antagonister
DE69734157D1 (en) Parathyroidhormon-verwandthe peptidanaloge
ZA200203701B (en) Polycycloalkylpurines as adenosine receptor antagonists.
AR030504A1 (es) Peptidos ciclicos selectivos
PL352367A1 (en) Glucagon antagonists/inverse agonists
WO1999010338A3 (en) Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
DE60006280D1 (de) Beta 2 -adrenergische rezeptor-agonisten
DK0695301T3 (da) Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne
WO2003107147A3 (en) METHOD AND SYSTEM FOR AUTOMATIC UPDATE OF MULTIPLE SERVERS
WO2001042265A3 (en) N6 heterocyclic 8-modified adenosine derivatives
WO1999049856A3 (en) Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
WO2001043806A3 (de) Atemzugsvolumenabhängige gasdosierung
MXPA04010625A (es) Antagonista de receptor de taquicinina.
ES2067322T3 (es) Lactamas substituidas en n utiles como antagonistas de colecistoquinina.
ZA9711435B (en) Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
IS6380A (is) Mótlyf viðtaka adenósíns og aðferðir til að búa þau til og nota
ZA983325B (en) NK-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome.
AR016981A2 (es) Polipeptidos sinteticos
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
WO2004056763A3 (en) Novel glucagon antagonists
BR9906391A (pt) "processo para a produção de n-metil pirrolidona".
CA2145866A1 (en) Human calcitonin receptor
CA2286296A1 (en) Inhibitors for urokinase receptor
DK0931161T3 (da) Fremgangsmåde til biotransformation af colchicinoid-forbindelser til de tilsvarende 3-glycosylderivater
ES2165766B2 (es) Metodo y aparato para soldar por chorro.